Design Therapeutics shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Design Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Design Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Design Therapeutics by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $32M | 5.2M | 6.30 |
| 2023-03-31 | $30M | 5.2M | 5.77 |
| 2022-12-31 | $53M | 5.2M | 10.26 |
| 2022-09-30 | $84M | 5.0M | 16.72 |
| 2022-06-30 | $77M | 5.5M | 14.00 |
| 2022-03-31 | $83M | 5.2M | 16.15 |
| 2021-12-31 | $117M | 5.4M | 21.41 |
| 2021-09-30 | $79M | 5.4M | 14.69 |
| 2021-06-30 | $106M | 5.4M | 19.57 |
| 2021-03-31 | $146M | 5.1M | 28.62 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management